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Abstract 
This paper focuses on reporting the in vivo antibacterial activity of 
dihydroanthracene disulfonic acid derivative preparation in a case diagnosed 
with mixed flora infection with streptococci, enterobacteria, bacterium coli, 
pseudomonas and anaerobic proteus that resulted in a resistant to ampicillin, 
piperacillin, ceftazidim, imipenem, and which is moderately sensitive to 
cotrimoxazole and azithromycin. This resistant infection affected a patient 
with history of alcohol and tobacco consumption. It later became complicated 
with Necrotizing Fasciitis after colon cancer surgery. This study is an in vivo 
study, which is aimed to measure the antibacterial activity of our new 
preparation against multiresistant mixed bacterial infection. In the situation 
of this difficult and almost hopeless case, the patient started oral and local 
treatment with dihydroanthracene disulfonic acid derivative. Although the 
fatality of the case was due to the antibiotics resistance, the patient's treatment 
was attributed to the antibacterial effect of the preparation used. A significant 
improvement was observed in the first 24 hours after the beginning of the 
treatment. This happened when all parenteral antibiotics were interrupted. 
The improvement continued and within a couple of weeks, the wounds were 
clean and with visible granulation. After three months, the wounds cicatrized 
“per secundam”. In order to have a general conclusion regarding the in vivo 
study related to the treatment with dihydroanthracene disulfonic acid 
derivative preparation, other results are needed. The significant effect shown 
in the above case, demonstrates that this preparation is promising for treating 
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life threatening resistant microorganisms infections. Further studies are 
needed to evaluate the full pharmacological activity of the new preparation.  
 
Keywords: Antimicrobial activity, Necrotizing Fasciitis, dihydroanthracene 
disulfonic acid derivative preparation 
 
Introduction 
A male patient with the initials Z.P., 61 years old from Elbasan, 
diagnosed with Adenocarcinoma of the sigmoid colon (American Cancer 
Society, 2017), hospitalized in the University Hospital Center "Mother 
Theresa" Tirana, in the General Surgery Clinic underwent surgery on 
19.11.2015 for "Anterior upper resection with temporary colostomy 
Hartmann's procedure" (Adams, Mann, Bokey, et al., 1992). The patient had 
a good postoperative decay, a functional colostomy on day three, without 
fever. On 25.11.2015, the patient left the hospital. He had a functional 
colostomy and diuresis about 2700 ml/24 hours. Clinically, one week after 
the hospital dismissal, a wound infection appeared at the lower corner of the 
stoma of the patient. On 04.12.2015, the patient was present at the Emergency 
Department with a complicated infection of the wound, body temperature of 
38.5°C, complaining of severe pain on the left side of the back (Janeviscus, 
Hann, & Butt, 1982) where red spots and crepitations during palpitation 
appeared. The patient was hospitalized and in addition to the surgery incision 
and the anus praeter, 24 parallel incisions in the median dorsal line were 
performed. The secretions smelled stingy because of the necrotic tissue 
present in the wounds. The patient was diagnosed with Necrotizing Fasciitis 
(Ahrenholz, 1988) complication post colon resection (Lancerotto, Tocco, 
Salmaso, et al., 2012; Rea, & Wyrick, 1970; Wilson, 1952). Removal of the 
necrotic tissue and local treatment were performed twice daily and 
oxygenated water, potassium permanganate, and hypertonic solution were 
administered.  
Antibiotics administered systemically comprises of:   
1) Cefazoline three times daily x 1.0 g intravenously;  
2) Metronidazol three times daily x 100 ml intravenously; and  
3) Gentamycine twice daily x 80 mg intravenously. 
The therapy employed also consists of: 
4) Ranitidine four times daily x 50 mg intravenously; 
5) Dalteparine once daily x 5000 UI S.C injection; 
6) NaCl solution 0.9 % / 500 ml, KCl solution 7.5 % / 20 ml, CaCl2 10 
% / 5 ml x three times daily intravenously; 
7) Diclofenac twice daily x 75 mg intravenously. 
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On 12.12.2015, Cefazoline was replaced with Ceftazidime twice daily 
x 2.0 g intravenously. Despite the careful systemic and local treatment 
(Swain, Hatcher, Azadian, et al., 2013; Roemmele & Batdorff, 2015), the 
measured body temperature was 38-39°C with a stingy odor from the wounds. 
The patient´s situation was not improving. However, this indicates the gravity 
of the condition and the low effectiveness of the treatment. On 18.12.2015, 
all three antibiotics were removed and replaced with Moxifloxacine once 
daily x 400 ml intravenously. Despite that, the situation did not improve and 
the toxicity increased. The clinical situation from 04.12.2015 to 17.12.2015 
showed that despite the careful local treatment and the combination of 
antibiotics administered intravenously (Janeviscus, Hann, & Butt, 1982), the 
treatment was not successful. Biochemical analysis determined anemia and 
impared hepatic function. Microbiological analysis resulted in mixed flora 
with streptococci, enterobacteria, bacterium coli, pseudomonas, and 
anaerobic proteus (Ahrenholz, 1988; Roemmele & Batdorff, 2015; Vayvada, 
Demirdover, Menderes, et al., 2012). This, therefore, resulted in a resistant to 
ampicillin, amoxicillin, piperacillin, cephalotin, ceftazidim, gentamicin, 
imipenem, and is moderately sensitive to cotrimoxazole and azithromycin. 
After a multidisciplinary consultation with pharmacologists, evaluating the 
microorganism's resistance to antibiotics and impaired hepatic function, it 
was decided that the patient should stop taking the antibiotics. Clinically, the 
patient was in a critical condition which is getting worse every day. The 
Faculty of Medicine was engaged in the studies of the effects of 
dihydroanthracene disulfonic acid derivative. 
 
Methods 
Study Design: Case Report 
This study is an in vivo study, which is aimed to measure the 
antibacterial activity of our new preparation against multiresistant mixed 
bacterial infection. In the situation of this difficult and almost hopeless case, 
following the patient´s and family consent, it was decided that the patient 
should start an oral treatment with dihydroanthracene disulfonic acid 
derivative twice daily x 2 g and a local treatment with a 20% solution of 
dihydroanthracene disulfonic acid derivative. To evaluate the effectiveness of 
the in vivo treatment and the antibacterial activity of dihydroanthracene 
disulfonic acid derivative, on 17.12.2015, this preparation was applied locally 
only on one of the 24 wounds. It was very clear that after 24 hours, in the 
wound treated with the solution of the dihydroanthracene disulfonic acid 
derivative, the necrotic tissue was noticeably reduced and the margins of the 
treated wound became more vital. This was the evidence of the efficacy of the 
preparation used in vivo. 
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Treatment: After this first step of testing the effectiveness and 
tolerance of the preparation, together with the local treatment as listed above, 
dihydroanthracene disulfonic acid derivative was used twice both locally and 
orally.  
 
Results 
From the first day of treatment, a decrease of the stingy odor up to 60% 
was observed. Only 24 hours after the first administration, the body 
temperature measured dropped to 37°C and the stingy odor of the wounds 
decreased noticeably. On the third to fifth day, cleaner wounds with visible 
granulation in the margins were observed. The measured body temperature 
was 37°C. The stingy putrid odor decreased up to 80%. Every day during the 
local treatment, necrotic tissue (Rea & Wyrick, 1970; Giuliano, Lewis, 
Hadley, et al., 1977) as shown in Figure 1 were removed, but the amount of 
the necrotic tissue after the fourth day decreased. 
 
Figure 1. Necrotic tissue removed from the wounds 
 
Figure 2. Scanner performed in patient 
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The scanner image presented in Figure 2 performed on 24.12.2015 
showed deep pockets in the wounds created after the mechanical removal of 
necrotic tissue [6, 11]. On 28.12.2015, the patient was well nourished by 
mouth, slept well and was afebrile. On 08.01.2016, a clean wounded patient 
without necrotic tissue (Rea & Wyrick, 1970; Giuliano, Lewis, Hadley, et al., 
1977) and pus was transferred to his birthplace in Elbasan hospital. During the 
treatment of this fatal case, the condition of the patient improved until 
recovery. Thus, the situation of the patient improved as shown below in 
Figures 3-11. When all parenteral antibiotics were stopped, the local treatment 
of one of the 24 wounds after 24 hours showed clear improvement. The next 
day following oral treatment and local treatment, the body temperature 
dropped to 37°C. The 24 incisions with purulent secretions cleared quickly. 
The results confirmed the in vivo antibacterial activity of the preparation 
against mixed bacterial flora with resistant life threatening microorganisms 
(Ahrenholz, 1988). With this new treatment, the infection was dominated 
within three to four days and the bad odor of the wounds almost disappeared 
indicating a fast dominance of anaerobes. After five to six days of treatment, 
the granulation of the wounds began. The total area of 24 wounds from about 
200 cm2 reduced significantly and after two months all the wounds were 
closed cicatrising “per secundam”. 
 
Figure 3. Wounds conditions on the left part of the body on 04.01.2016 
 
Figure 4. Wounds conditions on the right part of the body on 04.01.2016 
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Figure 5. Wounds conditions on 16.01.2016 
 
 
Figure 6. Wounds conditions on the left part of the body on 23.01.2016 
 
 
Figure 7. Wounds conditions on the right part of the body on 23.01.2016 
European Scientific Journal October 2018 edition Vol.14, No.30 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
34 
 
Figure 8. Wounds conditions on 12.02.2016 
 
 
Figure 9. Wounds conditions on 03.03.2016 
 
 
Figure 10. Wounds conditions on 21.03.2016 
European Scientific Journal October 2018 edition Vol.14, No.30 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
35 
 
Figure 11. Wounds conditions on 29.04.2016 
 
Discussion 
Necrotizing Fasciitis is a severe, rare, potentially lethal soft tissue 
infection that develops in the scrotum and perineum, the abdominal wall, or 
the extremities. The infection progresses rapidly, and septic shock may ensue; 
hence, the mortality rate is high (median mortality 32.2%) that approaches 
100% without treatment (Misiakos, Bagias, Patapis, et al., 2014). Necrotizing 
fasciitis is known throughout the world for its high lethality (Ahrenholz, 1988; 
Swain, Hatcher, Azadian, et al., 2013; Roemmele & Batdorff, 2015). 
Nevertheless, this case was fatal because the resistance to all antibiotics and 
curing of the patient is attributed to the antibacterial effectiveness of the used 
preparation dihydroanthracene disulfonic acid derivative due to the fact that 
significant improvement was observed in the first 24 hours after the beggining 
of the treatment, especially after all parenteral antibiotics were stopped. The 
improvement progressed and within weeks, the wounds were clean and with 
visible granulation. Undoubtedly, the in vivo results of dihydroanthracene 
disulfonic acid derivative are very promising, and they may be adopted by 
more physicians in the future. 
 
Conclusion 
In order to have a general conclusion regarding the in vivo study 
related to the treatment with dihydroanthracene disulfonic acid derivative, 
other results are needed. Thus, the evidence shown in the above case 
demonstrates that this preparation had an antibacterial activity on such a 
serious and critical life threatening situation which allows us to confirm that it 
will act equally in resistant microorganisms solitary wounds. 
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